ReviewFrontiers in oncology2023

Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer.

Yu-Chen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.